eSense-Lab (ASX:ESE) announced a new terpene purchase order from its previously established agreement with E-Quits, a e-liquid manufacturer in the United Kingdom (UK).

As quoted in the press release:

As per the terms of the commercial agreement with E-Quits and the previous purchase of eSense-Lab products, the Company is pleased to announce that a new order totalling 5 litres of material valued at US$12,500 has been ordered by E-Quits, based on the Company’s Super Lemon Haze product, for distribution in the United Kingdom. The material will be used over the next 3 months.

The Company expects an increase in shipments of its terpene blends as e-Quits continues to expand its distribution and sales of its product.

Commenting on the above announcement, eSense’s CEO Mr. Haim Cohen, stated: “The continuation of the supply of our products to e-Quits is important as it points to the continued stability in have recurring orders for our terpenes. The recurring orders for our products show the satisfaction and trust our client has in our products.”

Click here to read the full press release.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less